Where is?, page-348

Back in late 2017, I have already pointed out some particular medical cannabis stocks are heavily overvalued, and MXC is definitely not the only one I mentioned.

If you don't believe in someone who has been working in the medical field for more than 10 years, but instead believing in your own sentiment or some unidentified investment "mentors/experts" on HC, then that's your choice, and suffering a substantial loss is a very unfortunate, but likely outcome.

Up to date, MXC's share price have fallen close to 70% from peak, so as other MM stocks that I have mentioned before (can check my last year posts). But I still believe my advice have successfully helped some people avoid such loss.

However, if there are any fundamental changes in the industry, which change my view, I will also let people know asap.